XML 77 R48.htm IDEA: XBRL DOCUMENT
v3.25.4

The Group’s Business Reorganization and General Information (Details) - USD ($) |  |  |  | 1 Months Ended | 12 Months Ended |  |
--- | --- | --- | --- | --- | --- | --- | ---
Jun. 16, 2025 | May 22, 2025 | May 14, 2025 | Jul. 31, 2025 | Jun. 30, 2025 | Jun. 30, 2024 | Jun. 30, 2023 | Nov. 14, 2025 | Jun. 30, 2022
The Group’s Business Reorganization and General Information [Line Items] |  |  |  |  |  |  |  |  |
Shares received |  | 1 |  |  |  |  |  |  |
Shares held |  |  | 10 |  | 80,370 | 60,083 |  |  |
Par value (in Dollars per share) |  | $ 0.1 |  |  |  |  |  | $ 1 |
Number of shares reverse stock split |  | 10 |  |  |  |  |  |  |
Percentage of issued and outstanding equity interests | 50.00% | 50.00% |  |  |  |  |  |  |
Consideration for issued ordinary shares value | 6,200,000 |  |  |  |  |  |  |  |
Private warrant shares |  | 500,000 |  |  |  |  |  |  |
Private warrants exercise price (in Dollars per share) | $ 20 | $ 20 |  |  |  |  |  |  |
Additional ordinary shares issue |  | 12 months |  |  |  |  |  |  |
Shares outstanding, percentage | 77.00% |  |  |  |  |  |  |  |
Voting interest percentage | 98.00% |  |  |  |  |  |  |  |
Current debt (in Dollars) |  |  |  |  | $ 58,000,000 |  |  |  |
Working capital (in Dollars) |  |  |  |  | (204,860,444) |  |  |  |
Shareholders' deficit (in Dollars) |  |  |  |  | (82,873,602) | $ 250,001,370 | $ 258,570,102 |  | $ 124,869,117
Operating loss (in Dollars) |  |  |  |  | (104,150,129) | 19,284,982 | 98,045,630 |  |
Estimated gain (in Dollars) |  |  |  |  | 9,500,000 |  |  |  |
Moolec Science (Luxembourg) [Member[ |  |  |  |  |  |  |  |  |
The Group’s Business Reorganization and General Information [Line Items] |  |  |  |  |  |  |  |  |
Consolidation ratio |  |  | ten-to-one |  |  |  |  |  |
Shares received |  |  | 1 |  |  |  |  |  |
Moolec Science (Cayman Islands) [Member] |  |  |  |  |  |  |  |  |
The Group’s Business Reorganization and General Information [Line Items] |  |  |  |  |  |  |  |  |
Par value (in Dollars per share) |  | $ 0.1 |  |  |  |  |  |  |
Bioceres S.A [Member] |  |  |  |  |  |  |  |  |
The Group’s Business Reorganization and General Information [Line Items] |  |  |  |  |  |  |  |  |
Borrowings (in Dollars) |  |  |  |  | 36,400,000 |  |  |  |
Shareholders' deficit (in Dollars) |  |  |  |  | (91,042,130) | 54,026,136 |  |  |
Operating loss (in Dollars) |  |  |  |  | (91,566,943) | $ (5,145,053) | $ 3,194,004 |  |
Approximate gain (in Dollars) |  |  |  |  | 91,000,000 |  |  |  |
Bioceres LLC [Member] |  |  |  |  |  |  |  |  |
The Group’s Business Reorganization and General Information [Line Items] |  |  |  |  |  |  |  |  |
Approximate gain (in Dollars) |  |  |  |  | $ 5,300,000 |  |  |  |
Subsequent Events [Member] | Bioceres S.A [Member] |  |  |  |  |  |  |  |  |
The Group’s Business Reorganization and General Information [Line Items] |  |  |  |  |  |  |  |  |
Finance debt (in Dollars) |  |  |  | $ 69,500,000 |  |  |  |  |
Shares pledged |  |  |  | 3,062,500 |  |  |  |  |
Bioceres Group Limited [Member] |  |  |  |  |  |  |  |  |
The Group’s Business Reorganization and General Information [Line Items] |  |  |  |  |  |  |  |  |
Shares received | 500,000 | 450,000 |  |  |  |  |  |  |
Consideration for issued ordinary shares value |  | 6,200,000 |  |  |  |  |  |  |
Bioceres Group Limited [Member] | Ordinary Shares [Member] |  |  |  |  |  |  |  |  |
The Group’s Business Reorganization and General Information [Line Items] |  |  |  |  |  |  |  |  |
Shares received |  | 50,000 |  |  |  |  |  |  |
Consideration for issued ordinary shares value |  | 700,000 |  |  |  |  |  |  |
Gentle Tech [Member] |  |  |  |  |  |  |  |  |
The Group’s Business Reorganization and General Information [Line Items] |  |  |  |  |  |  |  |  |
Shares received |  | 132,750 |  |  |  |  |  |  |
Gentle Tech [Member] | Ordinary Shares [Member] |  |  |  |  |  |  |  |  |
The Group’s Business Reorganization and General Information [Line Items] |  |  |  |  |  |  |  |  |
Shares received |  | 14,750 |  |  |  |  |  |  |
Holdback [Member] |  |  |  |  |  |  |  |  |
The Group’s Business Reorganization and General Information [Line Items] |  |  |  |  |  |  |  |  |
Percentage of equity and voting interest acquired |  | 10.00% |  |  |  |  |  |  |

X
- Definition The amount of outstanding funds that the entity is obligated to repay. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 55 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_Borrowings
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of current debt instruments issued. [Refer: Debt instruments issued] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 55 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_CurrentDebtInstrumentsIssued
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of residual interest in the assets of the entity after deducting all its liabilities. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 1 -IssueDate 2025-01-01 -Paragraph 24 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_24_a&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 1 -IssueDate 2025-01-01 -Paragraph 32 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_32_a_i&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 13 -IssueDate 2025-01-01 -Paragraph 93 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_a&doctype=Standard -URIDate 2025-03-27 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 13 -IssueDate 2025-01-01 -Paragraph 93 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_e&doctype=Standard -URIDate 2025-03-27 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 13 -IssueDate 2025-01-01 -Paragraph 93 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_b&doctype=Standard -URIDate 2025-03-27 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 95 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95_b&doctype=Standard -URIDate 2025-03-27 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 28 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_28_a_i&doctype=Standard -URIDate 2025-03-27 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph B9 -Subparagraph f -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_f&doctype=Appendix&subtype=B -URIDate 2025-03-27 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 24 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_24_a&doctype=Standard -URIDate 2025-03-27 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 24 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_24_a&doctype=Standard -URIDate 2025-03-27 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 28 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_28_a_i&doctype=Standard -URIDate 2025-03-27 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 95 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95_b&doctype=Standard -URIDate 2025-03-27 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 95 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95_a&doctype=Standard -URIDate 2025-03-27 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 95 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95_a&doctype=Standard -URIDate 2025-03-27 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 55 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard -URIDate 2025-03-27 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 78 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_e&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_Equity
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 82 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_b&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_FinanceCosts
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of shares issued by the entity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 106 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_NumberOfSharesIssued
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The nominal value per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph B10 -Subparagraph a -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a_iii&doctype=Appendix&subtype=B -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 160 -Subparagraph a -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a_iii&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 79 -Subparagraph a -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a_iii&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_ParValuePerShare
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The percentage of voting equity interests acquired in a business combination. [Refer: Total for all business combinations [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2025-01-01 -Paragraph B64 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_c&doctype=Appendix&subtype=B -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 35 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35_c&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 35 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35_c&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_PercentageOfVotingEquityInterestsAcquired
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:percentItemType
Balance Type: | na
Period Type: | instant

X
- References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 32 -IssueDate 2025-01-01 -Paragraph IE33 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2025-en-r&anchor=para_IE33&doctype=Illustrative%20Examples -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 85 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_85&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_ProfitLossFromOperatingActivities
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The proportion of the voting rights in a subsidiary held by the entity. [Refer: Total for all subsidiaries [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2025-01-01 -Paragraph 17 -Subparagraph b -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b_iii&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2025-01-01 -Paragraph 16 -Subparagraph b -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b_iii&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2025-01-01 -Paragraph 19B -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_19B_c&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_ProportionOfVotingPowerHeldInSubsidiary
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of shares in the entity held by the entity or by its subsidiaries or associates. [Refer: Total for all associates [member]; Total for all subsidiaries [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 160 -Subparagraph a -Clause vi -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a_vi&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph B10 -Subparagraph a -Clause vi -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a_vi&doctype=Appendix&subtype=B -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 79 -Subparagraph a -Clause vi -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a_vi&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Additional ordinary shares issue. + References No definition available. + Details
Name: | mlec_AdditionalOrdinarySharesIssue
Namespace Prefix: | mlec_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of shares in consideration for issued ordinary share value. + References No definition available. + Details
Name: | mlec_ConsiderationForIssuedOrdinaryShareValue
Namespace Prefix: | mlec_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of gain (loss) on derecognition transactions. + References No definition available. + Details
Name: | mlec_GainlossOfDerecognitionTransactions
Namespace Prefix: | mlec_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of gain (loss) on recognition transactions. + References No definition available. + Details
Name: | mlec_GainlossOfRecognitionTransactions
Namespace Prefix: | mlec_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Percentage of number of shares outstanding. + References No definition available. + Details
Name: | mlec_NumberOfSharesOutstandingPercentage
Namespace Prefix: | mlec_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Total number of shares pledged. + References No definition available. + Details
Name: | mlec_NumberOfSharesPledged
Namespace Prefix: | mlec_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of shares under reverse stock split. + References No definition available. + Details
Name: | mlec_NumberOfSharesReverseStockSplit
Namespace Prefix: | mlec_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Percentage of issued and outstanding equity interests. + References No definition available. + Details
Name: | mlec_PercentageOfIssuedAndOutstandingEquityInterests
Namespace Prefix: | mlec_
Data Type: | dtr1:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Private warrants exercise price. + References No definition available. + Details
Name: | mlec_PrivateWarrantsExercisePrice
Namespace Prefix: | mlec_
Data Type: | dtr1:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Private warrants shares. + References No definition available. + Details
Name: | mlec_PrivateWarrantsShares
Namespace Prefix: | mlec_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Description of reverse stock split consolidation ratio. + References No definition available. + Details
Name: | mlec_ReverseStockSplitConsolidationRatio
Namespace Prefix: | mlec_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of working capital. + References No definition available. + Details
Name: | mlec_WorkingCapital
Namespace Prefix: | mlec_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=mlec_MoolecScienceLuxembourgMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=mlec_MoolecScienceCaymanIslandsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=mlec_BioceresSAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=mlec_BioceresLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=mlec_SubsequentEventsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresGroupLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfOrdinarySharesAxis=mlec_OrdinarySharesOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_GentleTechMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=mlec_HoldbackMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |